A Bulk Drug Manufacturing entity is looking to Sellout.
Posted By - Investment Banker
Posted date - 22/06/2021
BUSINESS BRIEF
- Financial highlights-
|
Year |
Sales (in INR Million) |
EBITDA(in INR million) |
|
2020 |
642 |
22 |
|
2021 |
740 |
16 |
The Company is a WHO-GMP Certified Pharmaceutical Company engaged in bulk drug manufacturing since 2004 and located in the Baddi area , Himachal Pradesh with 5648 sq.mt plot and covered area of 3776 sq.mts . The Company manufactures tablets and capsules , Ointment / Creams , Liquid Soaps , dry syrups and nutritional and dietary supplements.The Company has a full fledged machine plant setup with a capacity to produce 90 Million tablets and 10 million capsules per month per shift.
Proposal
Industry
Pharmaceuticals
Sub Industry
Integrated
Deal Size
INR 70 - 75 Cr
Motives For Sellout
Sellout
Management is open to continue with the business for handholding the new investor/buyers
Business Operation Information
Industry
Pharmaceuticals
Sub-Industry
Integrated
Type
Location
Major Products
Major Customers
Export
Division
Formulation Type
Major Products
Export
Financial Information |
2018 (in Cr) | 2019 (in Cr) | 2020 (in Cr) | 2021 (in Cr) |
|---|---|---|---|---|
Sales |
N.D | INR 52.4 Cr | INR 64.2 Cr | INR 57 Cr |
EBITDA |
||||
PAT |
N.D | N.D | N.D | N.D |
TOTAL DEBT |
